Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1446]
News [2942]
Articles [129]
Editorials [5]
Conferences [154]
elearning [6]
Best of ASH 2014
Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert...
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014
ASH 2014: Highlights in CLL from ASH 2014
Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014
Hope for avoiding chemo in patients with Hodgkins lymphoma
Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Hope for avoiding chemo in patients with Hodgkins lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014
ASH 2014: Highlights in mantle cell lymphoma
Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014
Paediatric leukaemia treatment regimens lead to improved outcomes in...
Dr Wendy Stock - University of Chicago, Chicago, USA
Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults ( Dr Wendy Stock - University of Chicago, Chicago, USA )
7 Dec 2014
Children with rare leukaemia have better-than-expected outcomes after tailored...
Dr Brent Wood - Seattle Children's Hospital, Seattle, USA
Children with rare leukaemia have better-than-expected outcomes after tailored treatment ( Dr Brent Wood - Seattle Children's Hospital, Seattle, USA )
7 Dec 2014
ASH 2014: Expert discussion on the latest in AML
Prof Alan Burnett and Prof Sergio Amadori
ASH 2014: Expert discussion on the latest in AML ( Prof Alan Burnett and Prof Sergio Amadori )
7 Dec 2014
ASH 2014: Expert discussion on the latest in CLL
Prof John Gribben and Prof Stephan Stilgenbauer
ASH 2014: Expert discussion on the latest in CLL ( Prof John Gribben and Prof Stephan Stilgenbauer )
7 Dec 2014
Daratumumab plus standard treatment improves outcomes in relapsed, hard-to...
Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain
Daratumumab plus standard treatment improves outcomes in relapsed, hard-to-treat multiple myeloma in phase I study ( Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain )
7 Dec 2014
Carfilzomib represents potent, effective addition to standard multiple myeloma...
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
7 Dec 2014
Predicting the relapse of acute myeloid leukaemia with genetic screening
Dr Elaine Mardis - University of Washington, Washington, USA
Predicting the relapse of acute myeloid leukaemia with genetic screening ( Dr Elaine Mardis - University of Washington, Washington, USA )
2 Dec 2014
The work and aims of SPECTA for better clinical trials
Dr Vassilis Golfinopoulos - European Organization for Research and Treatment of...
The work and aims of SPECTA for better clinical trials ( Dr Vassilis Golfinopoulos - European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium )
27 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation